Login
Résultat de la recherche (1-14 par 14)Download
|
Symbol
|
KCLLTQ | WIALTQ | WHZLTQ | WMBLTQ | YVDLTQ | YQZLTQ | YRBLTQ | YRALTQ | YNOLTQ | ZLTLTQ | ZLZLTQ | ZTWLTQ | ZUDLTQ | ABBDTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Outperformance Certificate | Outperformance Certificate | Outperformance Certificate | Capped Outperformance Certificate | Outperformance Certificate | Capped Outperformance Certificate | Capped Outperformance Certificate | Capped Outperformance Certificate | Capped Outperformance Certificate | Outperformance Certificate | Capped Outperformance Certificate | Capped Outperformance Certificate | Outperformance Certificate | Participation Certificate |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | ICE Brent Crude Oil Front Month Future / NYMEX WTI Crude Oil Front Month Future | ICE Brent Crude Oil Front Month Future / NYMEX WTI Crude Oil Front Month Future | Straumann Hldg. AG | iShares Barclays 20+ Year TR | Lonza Group N | Clariant AG | Lonza Group N | Clariant AG | iShares Barclays 20+ Year TR | Nestlé S.A. | Barrick Gold Corp. / Market Vectors Junior Gold Miners ETF / Newmont Corp. | iShares $ Treasury Bond 20+yr UCITS ETF | Nasdaq 100 Index |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
26.09.2029 | 06.12.2024 | 06.12.2024 | 17.03.2025 | 01.12.2025 | 27.05.2025 | 27.11.2024 | 27.11.2024 | 27.05.2025 | 23.02.2026 | 02.10.2025 | 02.10.2025 | 09.04.2026 | 04.10.2028 |
|
Prix d'exercise
|
- | 75,68 | 75,68 | 129,95 | 89,80 | 357,20 | 13,33 | 357,20 | 13,33 | 92,70 | 94,36 | 15,81 | 3,4235 | 14 103,0925 |
| Demande | 81,95 | 87,97 | 87,78 | 83,88 | 100,67 | 134,48 | 81,80 | 132,44 | 79,87 | 94,71 | 77,37 | 111,30 | 95,95 | 100,71 |
| Offre | 82,75 | - | - | 84,68 | 101,48 | 135,56 | 82,60 | 133,50 | 80,67 | 95,51 | 78,15 | 112,19 | 96,75 | 101,52 |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)